The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
BTCRC-GI20-457: A phase II study of atezolizumab and bevacizumab in Child-Pugh B7 hepatocellular carcinoma (the AB7 Trial).
 
Kristen Renee Spencer
Consulting or Advisory Role - QED Therapeutics
 
Anita Ahmed Turk
Honoraria - Exelixis
Research Funding - Lilly (Inst)
 
Shikha Jain
Stock and Other Ownership Interests - Doximity
Honoraria - Healio; Magellan Health; Tempus
Consulting or Advisory Role - Healio; Magellan Health
Speakers' Bureau - Practicing Clinician Exchange
 
Kelsey Klute
Consulting or Advisory Role - Cancer Expert Now; Daiichi Sankyo/Lilly; Pfizer
Research Funding - AstraZeneca (Inst); FibroGen (Inst)
 
Sam Joseph Lubner
Stock and Other Ownership Interests - Elephas Bio
Consulting or Advisory Role - Elephas Bio
 
Dirk F. Moore
No Relationships to Disclose
 
Howard S. Hochster
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Elion Oncology; Genentech; Merck